explore -WSS

explore

author：Wikipedia 2025-09-29 23:12:27 - browse：32

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Smaller biotechs seek to piggyback on weight loss drug boom

WSS

The White House hikes tariffs on plastic syringes made in China

Is there really a nursing shortage in the U.S.?

Is there really a nursing shortage in the U.S.?

STAT Summit: How researchers deal with rejection

STAT Summit: The economic case for universal basic health care

Roche drug slashes death risk in early

hotspot

explore

Wikipedia

Medical records are filled with copy

STAT Summit: Meghan O’Rourke on making chronic illness visible

In Memoriam: Notable people who died in 2023

Oak Street deal isn't the answer to health care's woes

Hollywood unions extend contract negotiations for actors

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Trump demands the U.S. pay no more for drugs than other countries … again

Smaller biotechs seek to piggyback on weight loss drug boom

At least 13 dead in Texas as scorching temps continue

Cassava Sciences’ Alzheimer’s clinical trials should be halted

leisure time

Readout LOUD podcast: Live from the 2023 STAT Summit

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

UnitedHealth, Optum discontinue NaviHealth name

CZI to create biohub to build anti

CZI to create biohub to build anti

Fertility clinic egg and embryo storage is a disaster

focus

knowledge

focus

knowledge